Personalized pet longevity

More goodyears.Together.

Personalized longevity protocols designed around your pet's age, health profile, mobility, recovery, and long-term wellbeing.

  • Symptom-guided
  • Species-specific
  • Research use only
A grey-muzzled senior golden retriever resting on a wooden floor beside a mature tabby cat in soft daylight

The catalog

One device.Five researchcategories.

One device. Five research categories.

Every category ships in the same preloaded dual-chamber pen: measured, consistent, and simple to log. For research use only. Not for diagnosis, treatment, or as a substitute for veterinary care.

Translational signal

Mobility Pen

Movement & soft tissue

The most requested research category: stiffness after rest, slower stairs, shorter walks.

  • BPC-157
  • TB-500
What the research describes
Rodent and ex-vivo models describe effects on tendon, ligament and connective-tissue repair signalling.
What it does not establish
No controlled outcome data in pet dogs or cats. Nothing here establishes improved mobility in a companion animal.

Canine · Feline

Translational signal

Cellular Pen

Energy & cellular ageing

Coenzyme research aimed at mitochondrial output and cellular repair pathways.

  • NAD+ precursor
What the research describes
NAD+ biology is well described across model organisms, with age-related decline observed in multiple tissues.
What it does not establish
Lifespan or healthspan extension in dogs and cats is not established by current literature.

Canine · Feline

Investigational

Metabolic Pen

Body condition & appetite signalling

Body condition is the single best-supported lever in longevity research — this category studies the signalling behind it.

  • Incretin-class research compound
What the research describes
Lean body condition across life is associated with longer median lifespan in a paired-feeding canine cohort.
What it does not establish
Incretin-class compounds have no established safety or dosing profile in companion animals.

Canine

Investigational

Coat & Skin Pen

Barrier & appearance

Copper-peptide and antioxidant research relating to skin quality and coat condition.

  • GHK-Cu
  • Glutathione
What the research describes
In-vitro work describes matrix remodelling and antioxidant balance.
What it does not establish
Cosmetic or dermatologic outcomes in pets are not established.

Canine · Feline

Translational signal

Recovery Pen

After exertion

For research into the window after hard activity — working dogs, sport dogs, long recoveries.

  • BPC-157
  • Glycine complex
What the research describes
Preclinical models describe tissue-repair and inflammatory-signalling effects.
What it does not establish
Return-to-function timelines in companion animals are not established by this research.

Canine

For pet families

Symptom-guided

You describe what you are seeing at home. An AI match points to the research category that fits, with the citations attached. You decide what to read next.

  • Three questions, no account needed
  • AI suggestion with sources cited
  • Research use only — no diagnosis, no prescription
Start the symptom match

For clinics & research partners

Protocol-guided

The same pens and the same citations, organised for structured observation: baseline, interval notes, and a shared record of what was studied.

  • Evidence tier stated on every category
  • Structured intake and interval logging
  • No licensing required — research use only
Request research access
A mature tabby cat sitting in an open window, watching the garden

Healthspan philosophy

Not anti-aging.Pro-living.

Not anti-aging. Pro-living.

Healthspan is the life inside the years.

Move with ease

Support comfortable, confident movement and everyday activity.

Recover with resilience

Coordinate recovery around the pet's history, current care and real-life goals.

Stay engaged

Protect curiosity, connection and the routines that make life feel like theirs.

The flagship pathway

The ContinuumProtocol

The Continuum Protocol

A personalized path for movement, recovery, and the good years ahead.

Explore Continuum
A person walking an older labrador along a sunlit garden path
  1. 01

    Baseline

    Health history, current care, mobility and daily-life signals — the honest starting point.

  2. 02

    AI Suggestion

    Symptom-guided matching surfaces the research categories that fit what you're seeing. A suggestion, not a diagnosis or a review.

  3. 03

    Personalized Plan

    Species, life stage and goals shape the research-use-only plan — never a fixed list applied to every pet.

  4. 04

    Measure + Evolve

    Monitor meaningful signals over time and adjust responsibly as life changes.

  5. No one-size formula. No promises the evidence cannot carry.

How it works

Four steps, inthe right order.

How it works

1

Tell us about them

Age, breed, mobility, history and what a good day looks like.

2

Get an AI suggestion

Symptom-guided matching points to the research categories that fit — not a veterinary review.

3

Build the personalized protocol

Species, life stage and goals shape what belongs in the plan.

4

Track what matters and evolve

Revisit meaningful signals and adjust as life changes.

Science & evidence

Science, with thevolume turned down.

Science, with the volume turned down.

Promising is not the same as proven.

Source library

Last reviewed: July 2026

The reading list

What the researchsays aboutyour pet.

What the research says about your pet

Each entry states how the work applies to dogs and cats, the benefit it describes, and the line it does not cross. Follow any link to read the source yourself.

  • Metabolic PenJAVMA (Kealy et al.) · 2002

    Effects of diet restriction on life span and age-related changes in dogs

    Labrador Retrievers, 14-year paired cohort

    The single strongest longevity finding in companion dogs: littermate pairs fed 25% less across life were followed to end of life.

    The benefit described
    Lean-fed dogs lived a median 1.8 years longer and showed later onset of visible osteoarthritis.
    Where it stops
    Body condition, not any injectable or supplement, produced the effect. One breed, one facility.
    Read the source
  • Cellular PenDog Aging Project · 2021–ongoing

    TRIAD — Test of Rapamycin In Aging Dogs

    Companion dogs, ≥7 years, owner-enrolled

    The first large, double-blind, placebo-controlled longevity trial run in pet dogs living at home rather than in a laboratory.

    The benefit described
    Owners report a second benefit alongside the science: full cardiac, cognitive and blood screening surfaced conditions their dogs were not yet symptomatic for.
    Where it stops
    Results are not yet reported. Enrolment in a trial is not the same as an available product.
    Read the source
  • Cellular PenGeroScience (Urfer et al.) · 2017

    Short-term rapamycin in middle-aged companion dogs

    24 middle-aged pet dogs

    A safety-and-feasibility trial asking whether an ageing-pathway intervention can be given to household dogs at all.

    The benefit described
    No significant adverse effects at the doses used, with echocardiographic measures trending in the treated group.
    Where it stops
    Ten weeks, 24 dogs, no lifespan endpoint. A safety signal, not an outcome.
    Read the source
  • Cellular PenAging-biology literature · 2016–2024

    NAD+ decline with age and mitochondrial function

    Mammalian models; canine work emerging

    Explains why energy, recovery and cognition drift in older animals: NAD+ availability falls in multiple tissues with age.

    The benefit described
    Restoring NAD+ availability improves measures of mitochondrial output in model organisms.
    Where it stops
    No controlled healthspan or lifespan data in pet dogs or cats. Mechanism only.
    Read the source
  • Mobility PenPreclinical orthopaedic literature · 2011–2023

    Pentadecapeptide BPC-157 and tendon-to-bone healing

    Rat and ex-vivo tendon models

    The mechanistic basis behind the most-requested research category — stiffness after rest, slower stairs, shorter walks.

    The benefit described
    Accelerated tendon fibroblast outgrowth and improved tendon-to-bone healing in the models studied.
    Where it stops
    Rodent models. No controlled mobility outcomes in pet dogs or cats, and no established dosing.
    Read the source
  • Mobility PenVeterinary consensus guidance · 2018–2023

    Multimodal management of canine osteoarthritis

    Dogs, clinical population

    The established floor under any mobility research: weight, controlled exercise, rehabilitation, and veterinary-directed pain control.

    The benefit described
    Consistently improves comfort and function — the best-supported intervention available to a pet family today.
    Where it stops
    Does not reverse joint disease, and is not replaced by anything investigational.
    Read the source

In their words

Families alreadydoing thiswork.

Families already doing this work

Quoted from published interviews with owners enrolled in companion-animal longevity research. These are not testimonials for our products, and no outcome is implied.

  • I was interested because Madi was getting older and I knew that this study was a longevity study for dogs. I thought if I could extend her life and have good quality of life, that would be really fabulous.

    JoAnna

    Seattle, WA — University of Washington retiree

    Madi, Akita-Rottweiler mix, adopted 2009

    Dog Aging Project — TRIAD Tails
  • I'm thankful that I learned she had high blood pressure, because it's treatable, and I don't know that I would have known that otherwise.

    JoAnna

    On the trial's baseline screening

    Madi, screened at WSU College of Veterinary Medicine

    Dog Aging Project — TRIAD Tails
  • My goal is just to provide them with the best quality of life for as long as possible. I've certainly been provided with second chances in life, and I'd like to offer that to pets.

    Linda

    West Des Moines, IA — senior analytics analyst

    Sadie, lab/husky mix, adopted from a shelter in 2020

    Dog Aging Project — TRIAD Tails
  • I ended up realizing the importance of quality of life as they get older. I learned that Zoe was a lot healthier than I thought she was.

    Bill

    Georgetown, TX — enrolled Zoe at age 10

    Zoe, Labrador-Rottweiler mix, raised from a puppy

    Dog Aging Project — TRIAD Tails
  • Through participation, Sadie was potentially able to give back and contribute positively to the health, longevity and quality of life of others.

    Linda

    After Sadie's graduation from the trial

    Sadie, 2020–2025

    Dog Aging Project — TRIAD Tails

Two audiences

One mission.Two ways in.

One mission. Two ways in.

A veterinarian gently examining an older dog's shoulder in a bright clinic

For Veterinary Clinics

The same research-use-only categories, with evidence tiers and coordinated follow-up for your practice.

Explore Professional Access

Questions

Askedplainly.

Frequently asked questions

No. It is a personalized planning pathway. It begins with your pet's baseline and an AI research match, and what follows is shaped by their species, life stage and goals — not by a pre-set list. Everything is supplied for research use only.

Never. Your veterinarian remains the centre of your pet's care. Nothing here diagnoses, prescribes or treats — it is research information only, and anything clinical belongs with your veterinarian.

No, and we say so. We label each element as an established foundation, a translational signal, or an investigational option, and we describe what the evidence does not establish alongside what it does.

Yes. Planning is species-specific throughout — cats are not treated as smaller dogs, and mature and senior life stages are considered separately.

You receive an on-screen summary of the pathway your answers point toward, with the citations attached, so you can read the research behind each category yourself.

An older dog looking out over an open meadow at golden hour

The point of all of it

What would moregood years looklike for them?

What would more good years look like for them?

One more trail. One more favorite window. Thousands more ordinary moments—the ones that never feel ordinary later.

Start Their Longevity Profile